OneVentures
Team Portfolio Funds Entrepreneurs Blog News Investors
TeamPortfolioFundsEntrepreneursBlogNewsInvestors
OneVentures

Fresh funds for Qld needle-free vaccine tech start-up Vaxxas

 

Read more from the Australian Financial Review below.

Learn more
 
AFRCarolyn MillerOctober 6, 2020Vaxxas, Paul Kelly
Twitter LinkedIn0 0 Likes
Previous

Clinical Genomics Announces Medicare Coverage Applicable to COLVERA® (Liquid Biopsy Test to Detect Recurrence of Colorectal Cancer)

Media ReleaseCarolyn MillerNovember 16, 2020Clinical Genomics, Paul Kelly
Next

Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response

Media ReleaseCarolyn MillerOctober 6, 2020Paul Kelly, Vaxxas

Suite 13.02, 179 Elizabeth Street, Sydney NSW 2000

enquiries@one-ventures.com

+61 2 8205 7379

Disclaimer

Responsible Investment Policy

Privacy Policy

 
 
OneVentures Pty Ltd
179 Elizabeth Street (Suite 13.02),
Sydney, NSW, 2000,
Australia
+61 2 8205 7379 enquiries@one-ventures.com
Hours

Copyright © 2017 OneVentures Pty Ltd